Omepralan (Omeprazole)

Omeprazole, the active ingredient in Omepralan, is a Proton Pump Inhibitor presented as a strength/form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults and children. GNH USA supplies Omepralan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omepralan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omepralan is a proton‑pump inhibitor that acts on the gastric acid secretion pathway.

- Gastro‑esophageal reflux disease (GERD): Improves heartburn and esophageal irritation. - Peptic ulcer disease: Promotes healing of gastric and duodenal ulcers. - Zollinger‑Ellison syndrome: Controls excessive gastric acid production. - Erosive esophagitis: Heals inflammation of the esophageal lining. - NSAID‑induced ulcer prophylaxis: Reduces risk of ulcer formation in at‑risk patients.

Side effects may arise from      ​   …  …   …  …  …  ... 

Common           …  …  …: -      …  …   …  ...  -   … … …  ...  - … …   g    … … …  -  … … …  t   … place  t  g  d  d """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""